Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

about

Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

Item

http://www.wikidata.org/entity/Q53728725

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Plasma Growth Differentiation ...... with Congenital Heart Disease.

@en

Plasma Growth Differentiation ...... with Congenital Heart Disease.

@nl

type

Item

label

Plasma Growth Differentiation ...... with Congenital Heart Disease.

@en

Plasma Growth Differentiation ...... with Congenital Heart Disease.

@nl

prefLabel

Plasma Growth Differentiation ...... with Congenital Heart Disease.

@en

Plasma Growth Differentiation ...... with Congenital Heart Disease.

@nl

P1476

Plasma Growth Differentiation ...... with Congenital Heart Disease.

@en

P2093

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Dong Liu

http://www.w3.org/2001/XMLSchema#string

Gang Li

http://www.w3.org/2001/XMLSchema#string

Jian Zhao

http://www.w3.org/2001/XMLSchema#string

Peng Jia

http://www.w3.org/2001/XMLSchema#string

Ting Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Qiu Tan

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary Hypertension

GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective

Right ventricular adaptation and failure in pulmonary arterial hypertension.

Biomarkers for pediatric pulmonary arterial hypertension: challenges and recommendations.

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.

GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.

Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.

Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.

Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011.

P2888

s00246-017-1705-7

P304

1620-1626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00246-017-1705-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28819713

http://www.w3.org/2001/XMLSchema#string

P921

biomarker